AUTL - Autolus Therapeutics stock slide on pricing $150.0M ADS offering
- Autolus Therapeutics ( NASDAQ: AUTL ) shares sank 23.1% after-hours after the firm has priced its previously announced underwritten public offering of 75M American Depositary Shares representing 75M ordinary shares at a public offering price of $2.00/ADS, for total gross proceeds of $150.0M.
- All ADSs sold in the offering were offered by Autolus.
- Underwriters are granted a 30-day option to purchase up to an additional 11.25M ADSs at the public offering price.
- Offering is expected to close on December 13, 2022.
For further details see:
Autolus Therapeutics stock slide on pricing $150.0M ADS offering